Interstitial 6q21q23 duplication - variant of variable phenotype and incomplete penetrance or benign duplication? by unknown
CASE REPORT Open Access
Interstitial 6q21q23 duplication - variant of
variable phenotype and incomplete
penetrance or benign duplication?
Malgorzata I. Srebniak1*, Laura J. C. M. van Zutven1, Florence Petit2, Sonia Bouquillon3, Ilse P. J. van Heel1,
Maarten F. C. M. Knapen4,5, Jerome M. J. Cornette4, Andreas Kremer6, Diane Van Opstal1 and Karin E. M. Diderich1
Abstract
Background: Chromosome 6q duplication syndrome is a chromosome abnormality associated with characteristic
phenotypic features such as intellectual disability (ID), short stature, feeding difficulties, microcephaly, dysmorphic
features (prominent forehead, downslanting palpebral fissures, flat nasal bridge, tented upper lip, micrognathia,
short webbed neck) and joint contractures. Only a few cases of pure partial 6q trisomy have been published and
the severity of the phenotype seems to depend on the breakpoint position. Unfortunately, most of these cases
were identified using karyotyping or FISH, so breakpoints at the molecular level and thus gene content are not
known.
Cases presentation: We report the first two families with an interstitial 6q duplication identified by karyotyping
where the gene content and breakpoints were characterized with microarray. In family 1, the 6q22.1q23.2
duplication was detected in a female patient with ID. In family 2, the 6q21q22.33 duplication was identified in a
male fetus with multiple congenital malformations. In both families, the duplication seems to show phenotypic
heterogeneity and in family 1 also incomplete penetrance suggesting the co-existence of an “additional hit” in
affected patients. This “additional hit” was identified in the first family to be a microduplication in 16p11.2, a known
susceptibility locus (SL) for neurodevelopmental disorders, that co-segregated with an abnormal phenotype in the
affected family members.
Conclusions: Our study shows that interstitial 6q21q23 duplication may represent a private variant that is benign,
but may also contribute to developmental disorders of variable expressivity in a “multi-hit” model. Finding the
“additional hit” within the family is therefore very important for genetic counseling and assessment of the CNV
penetrance within the particular family.
Keywords: Interstitial 6q22.1q23.2 duplication, Interstitial duplication 6q21q22.33, 16p11.2 microduplication,
Susceptibility locus, Second hit hypothesis
Background
The chromosome 6q duplication syndrome is a known
chromosome abnormality associated with characteristic
phenotypic features such as severe intellectual disability
(ID), short stature, feeding difficulties, microcephaly,
dysmorphic features (prominent forehead, downslanting
palpebral fissures, flat nasal bridge, tented upper lip,
micrognathia, short webbed neck) and joint contractures
[1–5]. Most reported patients carry unbalanced translo-
cations leading to a partial trisomy 6q and a partial
monosomy of another chromosome. In these cases the
monosomic region of another chromosome is also of
great influence on the patient’s phenotype. There are
only several cases of pure partial 6q trisomy and the
severity of the phenotype seems to depend on the break-
point position. In general, terminal duplications with co-
existing monosomy of another chromosome region
cause severe phenotypes whereas patients with pure
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interstitial duplications seem to be only mildly affected
[6–8]. Unfortunately the breakpoints of the majority of
published cases were assessed with karyotyping or FISH,
which hampers finding critical regions for ID and other
features [9] so the genotype-phenotype studies in cases
characterized by microarray are of great value [10].
We report on two families with an interstitial imbalance
involving region 6q21q23: a familial duplication of
6q22.1q23.2 and one of 6q21q22.33. This is the first report
where the gene content and breakpoints of a microscopic-
ally visible interstitial 6q duplication was characterized
with microarray. In these families, some individuals carry-
ing the imbalance did not show any structural anomalies




A 23 year-old pregnant woman was referred to the de-
partment of Clinical Genetics due to isolated ID and a
familial interstitial duplication on chromosome 6 charac-
terized by karyotyping in the past. This duplication was
discovered in 1983 in a family member that was known
to suffer from ID, developmental delay (DD) and sei-
zures. The observed ID in this family varied from very
mild (low degrees and learning problems) to more severe
(accompanied by DD and seizures).
The partner of the pregnant patient was known to have
ID as well. He was an adopted child. His biological brother
was said to have ID as well. Neither further family history,
nor parental samples were available. Because of the preg-
nancy, our patient and her partner were investigated with
genomic SNP array (Illumina HumanCytoSNP-12) to
study their chromosomal constitution.
The pregnant patient carried an interstitial ~16.1 Mb
6q duplication and the array testing additionally re-
vealed a susceptibility locus (SL) for neurodevelopmen-
tal disorders: a ~580 kb 16p11.2 microduplication
(arr[hg19] 6q22.1q23.2(116,411,005-132,541,408)x3,16
p11.2(29,595,483-30,174,926)x3). The partner of the
pregnant patient was shown to carry another SL for neu-
rodevelopmental disorders, a ~806 kb 16p11.2 microdele-
tion (arr[hg19] 16p11.2(28,475,873-29,282,147)x1).
Because both partners had abnormal array results, pre-
natal diagnosis was advised. Amniocentesis was performed
at 15 5/7 weeks of gestation and diagnostic array testing
on uncultured amniotic fluid cells showed only the inter-
stitial 6q duplication (Fig. 1). In order to enable clinical in-
terpretation of this result, 4 other family members of the
pregnant woman, two healthy and two affected (one mild
and the other severe (the one that was karyotyped in
1983, see above)), were tested with SNP array. Two
healthy relatives turned out to carry only the 6q
duplication, whereas the two affected relatives carried
both the 6q duplication and the 16p11.2 microduplication.
As the fetus inherited only the 6q duplication, in the
absence of SL, the prognosis of the fetal phenotype may
be favorable. The second trimester fetal ultrasound in-
vestigations showed no structural anomalies. A healthy
baby boy without any dysmorphic features was born and
there were no developmental abnormalities noted so far
(follow up at the age of 1 year).
Family 2
A 34 year-old pregnant woman was referred to a clinical
geneticist after suspicion of fetal esophageal atresia at
third trimester ultrasound investigations, based on polyhy-
dramnios and lack of visualization of the stomach. This
was the first pregnancy of non-consanguineous parents.
Fetal karyotype (amniotic fluid) revealed an interstitial du-
plication on chromosome 6. SNP-array (Affymetrix
CytoScan HD) was performed, showing a 15.3 Mb dupli-
cation (arr[hg19]6q21q22.33(113,465,762-128,774,807)x3)
(Fig. 2). Given the combination of the duplication along
with fetal structural abnormalities, the parents opted for
termination of pregnancy at 33 weeks gestational age. The
male fetus had normal biometry: weight 2593 g, height
49 cm, occipitofrontal circumference (OFC) 29 cm. Dys-
morphic facial features were noted: short nose with ante-
verted nares and long eyelashes. Fetal autopsy confirmed
the esophageal atresia and revealed additional structural
abnormalities: an abnormal pulmonary lobulation (2 lobes
on right lung and 1 lobe on left lung), a Meckel’s diver-
ticulum, bilateral hydronephrosis, pancreatic ectopia, and
neuronal heterotopia of the cerebellum located on the
dentate nuclei.
Familial studies revealed that the mother was carrier
of the same interstitial duplication on chromosome 6
(karyotyping and Oligo aCGH Agilent 60 K), while her
parents had normal karyotypes. No additional copy
number variation was found in both the mother and the
fetus. The mother had previously experienced learning
difficulties, dyslexia and was known with a scoliosis. Car-
diac ultrasound showed no abnormalities. No cerebral
or abdominal imaging was performed. She works as a
nurse assistant in a hospital.
Discussion
In many laboratories over the world, genomic array testing
is now a first-tier cytogenetic test. The interpretation of
array results is mainly based on comparisons to CNVs in
control and patient populations [11]. Comparison to previ-
ously reported cases with microscopically visible chromo-
some anomalies, however, is problematic. The breakpoints
of the majority of published cases were assessed with karyo-
typing or FISH, which hampers the genotype-phenotype
correlation studies as these breakpoints often are not
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accurate enough to compare them with array results
[9]. In the karyotyping era a de novo unbalanced
euchromatic chromosome aberration used to be al-
most always interpreted as pathogenic, however rare
inherited variants were assumed to be benign and
interpreted as unbalanced euchromatic abnormalities
without phenotypic consequences (if inherited from a
normal parent) [12–17]. At that time susceptibility
CNVs (variants of variable expressivity and pheno-
typic heterogeneity) [18, 19], which expression seems
to depend on other (genetic and/or environmental)
factors, were less commonly known.
Phenotypes of 6q21q23 duplication carriers
The literature searched showed only 12 cases of intersti-
tial duplications in chromosome region 6q21-6q23
(Table 1, Fig. 3) [7, 20–26]. The phenotype show vari-
ability and as shown in Fig. 3 not all duplication cases
overlap with the families presented here. Congenital
malformations seem to be infrequent, with only few pa-
tients reported to have variable cardiac anomalies (right
ventricular hypertrophy, cardiomegaly, ventricular septal
defect, pulmonary stenosis) [24, 25], and one suspicion
of a corpus callosum agenesis [24]. The 6q duplications
in the current families seem to overlap with the ISCA
Fig. 1 Family 1: Log Ratio plots of Illumina CytoSNP-12: a – partial chromosome 6q plot showing the 6q duplication in family 1: the mother and
the fetus carry a 6q22q23 duplication. The arrows indicate the duplicated region. b - partial chromosome 16p plot showing the imbalances in
16p11: the father carries 16p11 microdeletion, the mother 16p11 microduplication, whereas the fetal array profile is normal for both 16p regions.
The arrows indicate the imbalances in parental samples
Fig. 2 Family 2: a -Karyotype in standard resolution for chromosome 6, showing the interstitial duplication (arrow). b -array results (Oligo aCGH
Agilent 60 K) for chromosome 6 in family 2 showing duplication of 6q present in family 2. c- The duplicated region and its gene content
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case and patients published by Goh et al., Pratt et al. and
Zneimer et al. [20, 24, 25], although the breakpoints
based on karyotyping could be highly imprecise. All
these patients presented with DD/mild ID and have
common craniofacial features with constant hypertelor-
ism and frequent mid-face hypoplasia with anteverted
nares [20, 24, 25]. Further, the two cases reported by
Pazooki et al. that only partially overlap with the dupli-
cation in family 2 also presented DD and similar dys-
morphic features (hypertelorism and anteverted nares),
but no congenital malformation.
Possible candidate genes for DD/ID in 6q21q23
Although the duplicated regions are large, we conducted
a gene content study to search for candidate genes that
may explain the ID/learning problems in presented fam-
ilies. Gene lists were generated using Nexus BioDiscov-
ery Copy Number 7.5 and the data were uploaded and
analyzed with QIAGEN’s Ingenuity® Pathway Analysis
(IPA®, QIAGEN Redwood City, www.ingenuity.com). A
list of genes and proteins related to ID was generated
using the Knowledge Base of IPA. In case of the 6q du-
plication in family 1, we did not find any candidate gene
that may explain the ID when duplicated, which may
support our hypothesis that the 6q duplication seems to
be benign if present alone. However, the proximal region
that was duplicated in family 2, but not in family 1
seems to have an interesting gene content. It contains four
OMIM genes: MARCKS, HDAC2, HS3ST5 and FRK, all
involved in brain function and development [27–30].
Interestingly it was shown that MARCKS expression is
significantly elevated (45 %) in the hippocampus of mice,
which exhibit impaired hippocampus-dependent learning
[27] and neuron-specific over-expression of HDAC2 de-
creased dendritic spine density, synapse number, synaptic
plasticity and memory formation [31]. Since all four genes
are involved in neural development, one could speculate
that if their expression is dosage dependent, their duplica-
tion may play a role in neurological phenotypes like ID,
DD and brain malformations. To our knowledge, so far,
there are no cases of whole gene duplications in
MARCKS, HDAC2 and HS3ST5 in control populations
(neither in Decipher Population CNVs, Toronto Data-
base of Genomic Variants, nor our in house controls),
and there is only one family published by Pazooki et al.
carrying a smaller duplication, but overlapping also
with MARCKS, HDAC2, HS3ST5 (Fig. 3) [26]. Unfortu-
nately these data are not enough evidence to claim that
duplication of MARCKS, HDAC2, HS3ST5 causes learn-
ing problems or ID/DD. The duplication of these genes
remains a variation of unknown clinical significance,
however it cannot be excluded that it may contribute to
learning problems when also other genes involved in
neurological phenotypes are deregulated.
The second hit hypothesis
The variability in phenotypes in patients shown in
Table 1 could be explained by different chromosome
breakpoints, however the duplications in the current
families show variability within a family as well. This
cannot be explained by different gene content, but it
may be a consequence of the presence of additional
anomalies in affected individuals.
The two-hit model has been introduced to explain the
phenotypic variability in genetic disorders [18, 19]. The
presence of the additional hit may modify phenotype, ei-
ther acting in an additive manner (independently adding
new features), or by participation in the same or similar
biochemical pathway causing more severe phenotypes
[32]. And indeed in family 1, the 6q22.1q23.2 duplication
seems to be an euchromatic variant without phenotypic
MARCKS, HDAC2, HS3ST5, FRK
Fig. 3 Breakpoints comparison (in GRCh37/hg19) in cases with dup 6q21q23 where molecular testing was done (minimal breakpoints based on
FISH/YAC or DNA markers or given by the authors of original papers, if appropriate lifted from other genome builds)
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consequences, as only the individuals carrying the 6q du-
plication and the additional susceptibility CNV showed
abnormal phenotypes. Family 1 shows very high pene-
trance of the susceptibility locus, when both chromosome
aberrations are present. Although this observation can be
reassuring for the fetus, we found prediction of the fetal
prognosis still problematic since the father of the fetus
carried a susceptibility locus for neurodevelopmental dis-
order, but the paternal “additional hit” remained un-
known. The fetus did not inherit the paternal SL,
nevertheless the paternal “additional hit” may have been
inherited and may influence the intellectual development
of the child.
In family 2, the interstitial 6q duplication seems to
show highly variable expression in the mother and
fetus. The fetus had dysmorphic features similar to
reported cases in the literature and multiple congeni-
tal malformations that were not described before. The
breakpoints and gene content were identical in the
mother, who only had learning difficulties in child-
hood. There are no healthy carriers of this duplication
in this family and the de novo occurrence of this
chromosomal duplication in the mother of the fetus
may be an argument for its causality for the pheno-
type. The “second hit” has not been identified by
microarray in this family and remains unresolved.
Genetic counseling for a future pregnancy remains
problematic: it is doubtful whether it is reasonable to
offer an invasive prenatal test, if the “additional hit”
is still unknown and if no fetal ultrasound abnormal-
ities are present. Given these limitations, the couple
has opted for preimplantation diagnosis.
Conclusions
Finding a rare euchromatic variant or a susceptibility
locus is challenging in both postnatal and prenatal
settings. Our study shows that the 6q22.1q23.2 dupli-
cation may represent a private variant that is benign
when present alone, but that may act as the “add-
itional/second hit” in SL carriers. We suggest that
also large benign CNVs can serve as “an additional
hit” and therefore our study supports the opinion of
Thomas Liehr that benign variants cannot be fully
neglected in genetic analysis [17]. The presented
family 1 supports “the multi-hit hypothesis” showing
that the penetrance of such a SL in families known
to carry an “additional hit” can be much higher than
predicted [33], which may explain the conflicting
conclusions on the association with an abnormal
phenotype in the papers on SL [34–36]. Finding the
“additional hit” within the family is therefore very
important for genetic counseling and the assessment
of the SL penetrance within the particular family.
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